Amgen K.K
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
See below for the Latest Amgen K.K News, Analysis, Profit Results, Share Price Information, and Commentary.
No more articles to show for this company
Join the community
Most Read
1. AHCC perkuat layanan kanker lewat program Patient Advisor 2. Mayapada alokasikan 25% belanja modal untuk dorong transformasi kesehatan digital 3. WA Health perluas sistem pesan digital untuk memperkuat respons darurat 4. Hong Kong perluas jaringan layanan primer dalam dorongan reformasi kesehatan 5. A1 Health hentikan penggunaan anestesi desflurane di IndonesiaResource Center
Events
Event News
Global medical innovations and AI-driven solutions in the spotlight
Medical Taiwan 2024 drew 280 exhibitors from 10 countries, boosting tech integration in healthcare.